Cefixime
Who holds supplier records for Cefixime? 12 organisations hold a current record for Cefixime: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (7), China (2), Germany (1) and South Korea (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Cefixime: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cefixime
Reading the evidence
- 12 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
7 of the 11 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Cefixime expires 14 Dec 2028. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (12)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Cefixime. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 26369 · latest filing Sept 2012
- COVALENT LABORATORIES PRIVATE LTDIndiaCEPActive DMF 27121 · latest filing Apr 2013
- Orchid Pharma LimitedIndiaCEP Company GMP cert on recordActive DMF 19960 · latest filing Nov 2006
- PURE AND CURE HEALTHCARE PRIVATE LTDIndiaCEPActive DMF 23474 · latest filing Jan 2010
- Qilu Antibiotics Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 36694 · latest filing Jul 2022
- Zhejiang Apeloa Tospo Pharmaceutical Co., Ltd.ChinaCEPActive DMF 41651 · latest filing Mar 2025
- Ceph Lifesciences Private LimitedIndiaActive DMF 19307 · latest filing Mar 2006
- DRUG MANUFACTURING COMPANYActive DMF 44299 · latest filing Jun 2026
- Lupin LimitedIndia Company GMP cert on recordActive DMF 15996 · latest filing May 2002
- Sandoz GmbHGermanyCEP Company GMP cert on recordActive DMF 27527 · latest filing Sept 2013
- UNIMARK REMEDIES LTDIndiaActive DMF 26047 · latest filing Jun 2012
- HANMI FINE CHEMICAL CO., LTD.South KoreaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (8)
Certificates of Suitability on the EDQM register for Cefixime, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 22 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ZHEJIANG APELOA TOSPO PHARMACEUTICAL CO., LTD. Jinhua | CN | CEP 2019-162 - Rev 02 Cefixime trihydrate | Sept 2026 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2025-538 - Rev 00 Cefixime trihydrate, Process-III | Jun 2026 | — |
| QILU ANTIBIOTICS PHARMACEUTICAL CO. LTD. Jinan | CN | CEP 2021-361 - Rev 01 Cefixime trihydrate, Process 2 | Jun 2025 | Inspected Jun 2026 Austria |
| PURE AND CURE HEALTHCARE PRIVATE LIMITED Punjab | IN | CEP 2009-005 - Rev 02 Cefixime trihydrate | Jan 2025 | — |
| ORCHID PHARMA LIMITED Alathur | IN | CEP 2002-125 - Rev 03 Cefixime trihydrate | Sept 2024 | Inspected Oct 2024 Poland |
| COVALENT LABORATORIES PRIVATE LIMITED Hyderabad | IN | CEP 2023-014 - Rev 00 Cefixime trihydrate | Jul 2024 | — |
| HANMI FINE CHEMICAL CO., LTD. Siheung-si | KR | R1-CEP 2002-155 - Rev 06 Cefixime trihydrate | Jul 2019 | — |
| SANDOZ GMBH Kundl | AT | R1-CEP 2009-347 - Rev 02 Cefixime trihydrate | Oct 2018 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (6)
Organisations whose Type II DMFs for Cefixime are no longer active. These show a past filing, not current supply.
Show all 6 historical records
- Kyongbo Pharmaceutical Co., Ltd.South · Inactive DMF 27033 · filed Apr 2013
- China · Inactive DMF 25390 · filed Sept 2011
- ORCHID CHEMICALS AND PHARMACEUTICALS LTDInactive DMF 17655 · filed Sept 2004
- India · Inactive DMF 16313 · filed Dec 2002
- LEDERLE LABORATORIESInactive DMF 13687 · filed Sept 1998
- Japan · Inactive DMF 9478 · filed Dec 1991
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (15 listed products contain Cefixime). The latest listed patent expires 14 Dec 2028. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Cefixime is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1541).
Chemical identity
- IUPAC name
- (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- Canonical SMILES
- C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O
- InChIKey
- OKBVVJOGVLARMR-QSWIMTSFSA-N
- Synonyms
- Anhydrous cefixime, Cefixima, Cefixime, Cefixime anhydrous, Cefixime hydrate, Cefixime trihydrate, Cefspan, Cephoral, Citropen, CL 284,635, CL-284635, FK 027
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Cephalosporin Antibacterial
- Chemical structure
- Cephalosporins
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Cefixime?
12 organisations hold an active US FDA Type II Drug Master File or a CEP for Cefixime: APITORIA PHARMA PRIVATE LTD (India), COVALENT LABORATORIES PRIVATE LTD (India), Orchid Pharma Limited (India), PURE AND CURE HEALTHCARE PRIVATE LTD (India), Qilu Antibiotics Pharmaceutical Co., Ltd. (China), Zhejiang Apeloa Tospo Pharmaceutical Co., Ltd. (China), Ceph Lifesciences Private Limited (India) and DRUG MANUFACTURING COMPANY, and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Cefixime Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 26369), COVALENT LABORATORIES PRIVATE LTD (DMF 27121), Orchid Pharma Limited (DMF 19960), PURE AND CURE HEALTHCARE PRIVATE LTD (DMF 23474), Qilu Antibiotics Pharmaceutical Co., Ltd. (DMF 36694), Zhejiang Apeloa Tospo Pharmaceutical Co., Ltd. (DMF 41651), Ceph Lifesciences Private Limited (DMF 19307) and DRUG MANUFACTURING COMPANY (DMF 44299) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Cefixime records mean?
6 organisations have only inactive Type II DMFs for Cefixime. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Cefixime have a European Certificate of Suitability?
Yes. 8 organisations hold a valid CEP for Cefixime on the EDQM register, including ZHEJIANG APELOA TOSPO PHARMACEUTICAL CO., LTD. Jinhua (CN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), QILU ANTIBIOTICS PHARMACEUTICAL CO. LTD. Jinan (CN), PURE AND CURE HEALTHCARE PRIVATE LIMITED Punjab (IN), ORCHID PHARMA LIMITED Alathur (IN) and COVALENT LABORATORIES PRIVATE LIMITED Hyderabad (IN) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Cefixime?
Yes. The latest patent listed for an approved US product containing Cefixime expires 14 Dec 2028, across 15 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Cefixime supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Cefixime?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.